INSPIRE MEDICAL SYSTEMS INC

NYSE: INSP (Inspire Medical Systems, Inc.)

Last update: 28 Oct, 9:14PM

77.17

-1.03 (-1.32%)

  • 1D -1.32%
  • 5D -9.22%
  • 1M -0.66%
  • 6M -51.70%
  • YTD -59.21%
  • 1Y -57.64%
  • 5Y -55.82%
Previous Close 78.20
Open 77.81
Volume 1,031,714
Avg. Volume (3M) 1,221,501
Market Cap 2,312,711,424
Price / Earnings (TTM) 44.87
Price / Earnings (Forward) 55.25
Price / Sales 2.79
Price / Book 3.57
52 Weeks Range
70.77 (-8%) — 216.01 (179%)
Earnings Date 3 Nov 2025
Profit Margin 7.92%
Operating Margin (TTM) -0.74%
Diluted EPS (TTM) 2.19
Quarterly Revenue Growth (YOY) 22.70%
Quarterly Earnings Growth (YOY) 138.60%
Total Debt/Equity (MRQ) 5.27%
Current Ratio (MRQ) 9.01
Operating Cash Flow (TTM) 114.68 M
Levered Free Cash Flow (TTM) 42.41 M
Return on Assets (TTM) 4.40%
Return on Equity (TTM) 10.86%

Market Trend

Short Term Medium Term
Industry Medical Devices (US) Mixed Mixed
Medical Devices (Global) Mixed Bearish
Stock Inspire Medical Systems, Inc. Bearish Bearish

AIStockmoo Score

0.9
Analyst Consensus 1.0
Insider Activity NA
Price Volatility 0.5
Technical Moving Averages 0.0
Technical Oscillators 2.0
Average 0.88

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
INSP 2 B - 44.87 3.57
GMED 11 B - 27.15 2.58
PEN 10 B - 63.68 8.06
GKOS 5 B - - 6.33
ITGR 2 B - 27.98 1.38
AORT 2 B - - 4.56

Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.
Sector Healthcare
Industry Medical Devices
Investment Style Small Growth
% Held by Insiders 1.11%
% Held by Institutions 119.04%

Ownership

Name Date Shares Held
Braidwell Lp 30 Jun 2025 522,410
52 Weeks Range
70.77 (-8%) — 216.01 (179%)
Price Target Range
82.00 (6%) — 135.00 (74%)
High 135.00 (Piper Sandler, 74.94%) Buy
Median 90.00 (16.63%)
Low 82.00 (JP Morgan, 6.26%) Hold
Average 101.33 (31.31%)
Total 4 Buy, 5 Hold
Avg. Price @ Call 82.85
Firm Date Target Price Call Price @ Call
JP Morgan 04 Nov 2025 82.00 (6.26%) Hold 85.01
Piper Sandler 04 Nov 2025 135.00 (74.94%) Buy 85.01
RBC Capital 04 Nov 2025 125.00 (61.98%) Buy 85.01
Truist Securities 04 Nov 2025 84.00 (8.85%) Hold 85.01
15 Oct 2025 90.00 (16.63%) Hold 78.84
Wells Fargo 04 Nov 2025 90.00 (16.63%) Buy 85.01
Jefferies 24 Oct 2025 85.00 (10.15%) Hold 77.52
Evercore ISI Group 07 Oct 2025 125.00 (61.98%) Buy 76.82
02 Sep 2025 150.00 (94.38%) Buy 94.51
UBS 22 Sep 2025 89.00 (15.33%) Hold 78.53
Leerink Partners 15 Aug 2025 97.00 (25.70%) Hold 87.77
Show more

No data within this time range.

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria